Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
10.34
+0.13 (1.27%)
At close: Jan 9, 2026, 4:00 PM EST
10.35
+0.01 (0.10%)
After-hours: Jan 9, 2026, 7:45 PM EST
Delcath Systems Market Cap
Delcath Systems has a market cap or net worth of $365.14 million as of January 9, 2026. Its market cap has decreased by -0.18% in one year.
Market Cap
365.14M
Enterprise Value
277.20M
1-Year Change
-0.18%
Ranking
Category
Stock Price
$10.34
Market Cap Chart
Since May 1, 2020, Delcath Systems's market cap has increased from $11.70M to $365.14M, an increase of 3,020.89%. That is a compound annual growth rate of 82.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 365.10M | 2.35% |
| Dec 31, 2025 | 356.70M | -7.35% |
| Dec 31, 2024 | 385.00M | 319.85% |
| Dec 29, 2023 | 91.70M | 195.81% |
| Dec 30, 2022 | 31.00M | -45.61% |
| Dec 31, 2021 | 57.00M | -22.76% |
| Dec 31, 2020 | 73.80M | 530.77% |
| May 1, 2020 | 11.70M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |